DrugDashboards

Atropine Sulfate

Atropine Sulfate · ATROPINE SULFATE .4 mg/mL · Injection, Solution · Intravenous · Medical Purchasing Solutions, LLC

NDC 71872-7312-01 · 1 VIAL, GLASS in 1 BAG / 1 mL in 1 VIAL, GLASS · ANDA · View full market →

The short version

13 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “requirements related to complying with good manufacturing practices”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $47.18 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA216120
TE code
AP
Approval date
May 26, 2022
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25)Jan 1, 2012
    month 177 — 9× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43)Jan 1, 2012
    Requirements related to complying with good manufacturing practices
    month 177 — 9× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)Jan 1, 2012
    month 177 — 9× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)Jan 1, 2012
    month 177 — 9× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25)Jan 1, 2012
    month 177 — 9× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)Jan 1, 2012
    Other
    month 177 — 9× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Atropine Sulfate (Injection, Solution)

LabelerStrengthFirst seenLast seen
Accord Healthcare Inc.ATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 2, 2026
American Regent, Inc.ATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 2, 2026
American Regent, Inc.ATROPINE SULFATE 1 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, IncATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.ATROPINE SULFATE .05 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.ATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.ATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.ATROPINE SULFATE 1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstATROPINE SULFATE 1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co. LLC, DBA Health FirstATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co., LLC, DBA Health FirstATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.ATROPINE SULFATE .05 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.ATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionATROPINE SULFATE 1 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.ATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCATROPINE SULFATE .1 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Atropine Sulfate — NDC 71872-7312-01," retrieved September 3, 2026, https://drugdashboards.com/drug/71872731201.

Free to cite with attribution — see how the data is put together.